News

Reducing the Costs of Medical Device Clinical Trials. Is This an Overlooked Aspect of Healthcare Reform? | Medical Device Podcast


Posted by mddiadmin on March 19, 2012

Interview with Molly Blake-Michaels


In a world where healthcare budgets are being constantly squeezed, it is paramount to ensure that one of the most fundamental steps in medical device development—the clinical trial—is planned as effectively and efficiently as possible. We enlisted the help of Molly Blake-Michaels, Senior Director of Clinical Services for ClearTrial, to enlighten us on the challenges unique to designing medical device clinical trials. In this interview, Molly shares her expertise regarding the planning, forecasting, and tracking of medical device clinical trials and the concepts that can be employed to help overcome them.

Okay, so who is Molly Blake-Michaels? She is the Senior Director of Clinical Services for ClearTrial. And what exactly is ClearTrial? ClearTrial provides Clinical Trial Operations (CTO) software that makes the planning, forecasting, and tracking of clinical project and financial performance faster and more accurate. Before joining ClearTrial, Molly spent over 20 years in clinical trial operations with companies like Abbott, Fujisawa, Hospira, and Delta Pharma.

Listen to the "Reducing the Costs of Medical Device Clinical Trials. Is This an Overlooked Aspect of Healthcare Reform?" podcast (right click and select "Save Link As" to download the podcast).

Download the PDF action points of the "Reducing the Costs of Medical Device Clinical Trials. Is This an Overlooked Aspect of Healthcare Reform?" podcast.


Tags:
Printer-friendly version
No votes yet

Login to post comments